A study assessing efficacy of Xience/Promus versus Cypher in patients receiving percutaneous intervention from the EXCELLENT (Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing) Registry.

Trial Profile

A study assessing efficacy of Xience/Promus versus Cypher in patients receiving percutaneous intervention from the EXCELLENT (Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing) Registry.

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Oct 2016

At a glance

  • Drugs Everolimus (Primary) ; Sirolimus (Primary)
  • Indications Coronary artery disease
  • Focus Therapeutic Use
  • Acronyms EXCELLENT
  • Most Recent Events

    • 09 Oct 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top